Related Experiment Videos
PDE-5 inhibitors: current status and future trends
Puneet Masson1, Sarah M Lambert, Melissa Brown
1Department of Urology, College of Physicians and Surgeons, Columbia University, 161 Fort Washington Avenue, New York, NY 10032, USA.
The Urologic Clinics of North America
|November 18, 2005
Summary
Phosphodiesterase-5 (PDE-5) inhibitors are proven effective and safe treatments for erectile dysfunction (ED). Future applications may include pulmonary hypertension and benign prostatic hyperplasia (BPH).
Area of Science:
- Pharmacology
- Urology
- Cardiology
Background:
- Phosphodiesterase-5 (PDE-5) inhibitors are a primary treatment for erectile dysfunction (ED).
- Extensive clinical data confirm their significant efficacy and safety profile in managing ED.
- Their effectiveness spans various causes and co-existing conditions in men with ED.
Purpose of the Study:
- To summarize the established efficacy and safety of PDE-5 inhibitors for ED.
- To explore potential future indications for PDE-5 inhibitors.
Main Methods:
- Review of extensive clinical trials and clinical experience.
- Analysis of established safety and efficacy data.
Main Results:
- PDE-5 inhibitors demonstrate significant efficacy and safety in treating ED across diverse patient populations.
- Established effectiveness in men with ED regardless of etiology or comorbidities.
Conclusions:
- PDE-5 inhibitors are a well-established, highly effective, and safe first-line therapy for ED.
- Potential future uses include treating pulmonary hypertension and symptomatic benign prostatic hyperplasia (BPH).